{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:18:21Z","timestamp":1792657101832,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.sapharm.2017.12.009","type":"journal-article","created":{"date-parts":[[2017,12,31]],"date-time":"2017-12-31T09:47:08Z","timestamp":1514713628000},"page":"910-916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Promising roles for pharmacists in addressing the U.S. opioid crisis"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3108-5118","authenticated-orcid":false,"given":"Wilson M.","family":"Compton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack B.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9890-0116","authenticated-orcid":false,"given":"Eric M.","family":"Wargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2017.12.009_bib1","series-title":"Drug Overdose Deaths in the United States, 1999-2016","author":"Hedegaard","year":"2017"},{"key":"10.1016\/j.sapharm.2017.12.009_bib2","unstructured":"National Center for Health Statistics, Provisional Counts of Drug Overdose Deaths as of 1\/2\/2018, Available at https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm, Accessed 2 January 2018."},{"key":"10.1016\/j.sapharm.2017.12.009_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/SAR.S144268","article-title":"The opioid overdose epidemic: opportunities for pharmacists","volume":"8","author":"Wu","year":"2017","journal-title":"Subst Abuse Rehabil"},{"issue":"8","key":"10.1016\/j.sapharm.2017.12.009_bib4","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.2105\/AJPH.2014.301966","article-title":"Determinants of increased opioid-related mortality in the United States and Canada, 1990-2013: a systematic review","volume":"104","author":"King","year":"2014","journal-title":"Am J Publ Health"},{"key":"10.1016\/j.sapharm.2017.12.009_bib5","series-title":"The Latest Prescription Trends for Controlled Prescription Drugs","author":"Jones","year":"2015"},{"issue":"1-2","key":"10.1016\/j.sapharm.2017.12.009_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2013.01.007","article-title":"Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers \u2013 United States, 2002\u20132004 and 2008\u20132010","volume":"132","author":"Jones","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.sapharm.2017.12.009_bib7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMra1508490","article-title":"Understanding the relationship between prescription opioid and heroin abuse","volume":"374","author":"Compton","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sapharm.2017.12.009_bib8","series-title":"2015 National Survey on Drug Use and Health: Detailed Tables","author":"Center for Behavioral Health Statistics and Quality (CBHSQ)","year":"2016"},{"key":"10.1016\/j.sapharm.2017.12.009_bib9","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.amepre.2017.06.009","article-title":"Geographic variation in opioid and heroin involved drug poisoning mortality rates","volume":"53","author":"Ruhm","year":"2017","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.sapharm.2017.12.009_bib10","series-title":"The Federal Government is Systematically Undercounting Heroin Users","author":"Humphreys","year":"2017"},{"key":"10.1016\/j.sapharm.2017.12.009_bib11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1176\/appi.ajp.2009.09081087","article-title":"The effect of inmate populations on estimates of DSM-IV alcohol and drug use disorders in the United States","volume":"167","author":"Compton","year":"2010","journal-title":"Am J Psychol"},{"key":"10.1016\/j.sapharm.2017.12.009_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.drugalcdep.2017.03.011","article-title":"Increases in prescription opioid injection abuse among treatment admissions in the United States, 2004-2013","volume":"176","author":"Jones","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"17","key":"10.1016\/j.sapharm.2017.12.009_bib13","first-page":"453","article-title":"Increases in hepatitis C virus infection related to injection drug use among persons aged \u226430 Years \u2014 Kentucky, Tennessee, Virginia, and West Virginia, 2006\u20132012","volume":"64","author":"Zibbell","year":"2015","journal-title":"Morb Mort Wkly"},{"issue":"3","key":"10.1016\/j.sapharm.2017.12.009_bib14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa1515195","article-title":"HIV infection linked to injection use of oxymorphone in Indiana, 2014\u20132015","volume":"375","author":"Peters","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sapharm.2017.12.009_bib15","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1056\/NEJMsa1500439","article-title":"Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs","volume":"372","author":"Tolia","year":"2015","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.sapharm.2017.12.009_bib16","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic Pain\u2014United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.sapharm.2017.12.009_bib17","series-title":"Associations of Nonmedical Pain Reliever Use and Initiation of Heroin Use in the United States","author":"Muhuri","year":"2013"},{"key":"10.1016\/j.sapharm.2017.12.009_bib18","series-title":"NDEWS HotSpot Report: Understanding Opioid Overdoses in New Hampshire","author":"Meier","year":"2017"},{"issue":"4","key":"10.1016\/j.sapharm.2017.12.009_bib19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.amepre.2015.03.040","article-title":"Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines","volume":"49","author":"Jones","year":"2015","journal-title":"Am J Prevent Med"},{"key":"10.1016\/j.sapharm.2017.12.009_bib20","doi-asserted-by":"crossref","DOI":"10.2174\/1389201018666170710184531","article-title":"Adulteration practices of psychoactive illicit drugs: an updated review","author":"Solimini","year":"2017","journal-title":"Curr Pharm Biotechnol"},{"issue":"3","key":"10.1016\/j.sapharm.2017.12.009_bib21","first-page":"434","article-title":"Secretary price announces HHS Strategy for fighting opioid crisis","volume":"13","author":"Price","year":"2012","journal-title":"Pain Med"},{"issue":"5","key":"10.1016\/j.sapharm.2017.12.009_bib22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/M17-0865","article-title":"Prescription opioid use, misuse, and use disorders in the U.S. adults: 2015 National Survey on Drug Use and Health","volume":"167","author":"Han","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.sapharm.2017.12.009_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugalcdep.2014.10.001","article-title":"What we know, and don't know, about the impact of state policy and systems-level interventions on prescription drug overdose","volume":"145","author":"Haegerich","year":"2014","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.sapharm.2017.12.009_bib24","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1526-4637.2012.01327.x","article-title":"Do prescription monitoring programs impact state trends in opioid abuse\/misuse?","volume":"13","author":"Reifler","year":"2012","journal-title":"Pain Med"},{"issue":"35","key":"10.1016\/j.sapharm.2017.12.009_bib25","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1377\/hlthaff.2015.1496","article-title":"Implementation of prescription drug monitoring programs associated with reductions in opioid related death rates","volume":"2016","author":"Patrick","year":"2016","journal-title":"Health Aff"},{"key":"10.1016\/j.sapharm.2017.12.009_bib26","first-page":"802","article-title":"Sources of prescription opioid pain relievers by frequency of past-year nonmedical use United States, 2008-2011","volume":"174","author":"Jones","year":"2014","journal-title":"J Intern Med"},{"key":"10.1016\/j.sapharm.2017.12.009_bib27","first-page":"10","article-title":"CDC grand rounds: prescription drug overdoses \u2013 a U.S. epidemic","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.sapharm.2017.12.009_bib28","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2017.0831","article-title":"Prescription opioid analgesics commonly unused after surgery: a systematic review","author":"Bicket","year":"2017","journal-title":"JAMA Surg"},{"issue":"15","key":"10.1016\/j.sapharm.2017.12.009_bib29","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/archinternmed.2012.2374","article-title":"Prescription drug abuse and DEA-sanctioned drug take-back events: characteristics and outcomes in rural Appalachia","volume":"172","author":"Gray","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.sapharm.2017.12.009_bib30","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1360-0443.2012.04005.x","article-title":"Development of dependence following treatment with opioid analgesics for pain relief: a systematic review","volume":"108","author":"Minozzi","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.sapharm.2017.12.009_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/M15-0038","article-title":"Opioid prescribing after nonfatal overdose and association with repeated overdose: a cohort study","volume":"164","author":"Larochelle","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.sapharm.2017.12.009_bib32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.amepre.2016.02.014","article-title":"Trends in the concomitant prescribing of opioids and benzodiazepines, 2002-2014","volume":"51","author":"Hwang","year":"2016","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.sapharm.2017.12.009_bib33","author":"U.S. Food and Drug Administration"},{"key":"10.1016\/j.sapharm.2017.12.009_bib34","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/j.japh.2017.01.017","article-title":"Pharmacy-based statewide naloxone distribution: a novel \u201ctop-down, bottom-up\u201d approach","volume":"57","author":"Morton","year":"2017","journal-title":"J Am Pharm Assoc."},{"key":"10.1016\/j.sapharm.2017.12.009_bib35","series-title":"Legal Science","year":"2017"},{"key":"10.1016\/j.sapharm.2017.12.009_bib36","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2105\/AJPH.2016.303062","article-title":"Increase in naloxone prescriptions dispensed in US retail pharmacies since 2013","volume":"106","author":"Jones","year":"2016","journal-title":"Am J Publ Health"},{"key":"10.1016\/j.sapharm.2017.12.009_bib37","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1177\/1060028014523730","article-title":"Naloxone for opioid overdose prevention: pharmacists' role in community-based practice settings","volume":"48","author":"Bailey","year":"2014","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.sapharm.2017.12.009_bib38","doi-asserted-by":"crossref","unstructured":"Klebacher R, Harris MI, Ariyaprakai N, Tagore A, Robbins V, Dudley LS, et al. Incidence of naloxone redosing in the age of the new opioid epidemic. Prehosp Emerg Care, DOI: 10.1080\/10903127.2017.1335818.","DOI":"10.1080\/10903127.2017.1335818"},{"key":"10.1016\/j.sapharm.2017.12.009_bib39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jsat.2014.11.006","article-title":"Factors associated with provision of addiction treatment information by community pharmacists","volume":"52","author":"Hagemeier","year":"2015","journal-title":"J Subst Abuse Treat"},{"issue":"377","key":"10.1016\/j.sapharm.2017.12.009_bib40","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1056\/NEJMsr1706626","article-title":"The role of science in addressing the opioid crisis","volume":"2017","author":"Volkow","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sapharm.2017.12.009_bib41","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature14886","article-title":"Structural insights into \u03bc-opioid receptor activation","volume":"524","author":"Huang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.sapharm.2017.12.009_bib42","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/2051013614537818","article-title":"Vaccines against drugs of abuse: where are we now?","volume":"2","author":"Kinsey","year":"2014","journal-title":"Ther Adv Vaccines"},{"key":"10.1016\/j.sapharm.2017.12.009_bib43","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1331\/JAPhA.2013.12094","article-title":"How does use of a prescription monitoring program change pharmacy practice?","volume":"53","author":"Green","year":"2013","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.sapharm.2017.12.009_bib44","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0955-3959(00)00047-5","article-title":"Involvement of community pharmacists in the care of drug misuers: pharmacy-based supervision of methadone consumption","volume":"11","author":"Luger","year":"2000","journal-title":"Int J Drug Pol"},{"key":"10.1016\/j.sapharm.2017.12.009_bib45","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/01.adt.0000210713.80198.d1","article-title":"Drucker Ernest. Safety, efficacy, and feasibility of office-based prescribing and community pharmacy dispensing of methadone: results of a pilot study in New Mexico","volume":"5","author":"Tuchman","year":"2006","journal-title":"Addict Disord Their Treat"},{"issue":"12","key":"10.1016\/j.sapharm.2017.12.009_bib46","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jpain.2011.06.006","article-title":"Pain education in North American medical schools","volume":"12","author":"Mezei","year":"2011","journal-title":"J Pain"},{"issue":"3","key":"10.1016\/j.sapharm.2017.12.009_bib47","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2146\/sp140002","article-title":"ASHP statement on the pharmacist's role in substance abuse prevention, education, and assistance","volume":"71","author":"American Society of Health-System Pharmacists (ASHP)","year":"2014","journal-title":"Am J Health Syst Pharm"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741117309774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741117309774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:17:36Z","timestamp":1761556656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741117309774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1551741117309774"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2017.12.009","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Promising roles for pharmacists in addressing the U.S. opioid crisis","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2017.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}